European Journal of Rheumatology
Short Communication

The emerging role of lung ultrasound in COVID-19 pneumonia


Division of Rheumatology, Department of Experimental and Clinical Medicine, Università degli Studi di Firenze, Firenze, Toscana, Italy


Department of Emergency, Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Florence, Italy


Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom


Department of Rheumatology and Immunology, Shantou Central Hospital, Shantou, China

Eur J Rheumatol 2020; 7: Supplement S129-S133
DOI: 10.5152/eurjrheum.2020.2063
Read: 2894 Downloads: 1428 Published: 07 May 2020

In the last decades lung ultrasound (LUS) has become of crucial importance in the evaluation and monitoring of a widely range of pulmonary diseases. One of the major benefits which favours this examination, is that this is a non-invasive, low-cost and radiation-free imaging modality which allows repeated imaging. LUS plays an important role in a wide range of pathologies, including cardiogenic oedema, acute respiratory distress syndrome and fibrosis. Specific LUS findings have proved useful and predictive of acute respiratory distress syndrome which is of particular relevance in the suspicion and monitoring of patients with lung disease. Furthermore, several studies have confirmed the role of LUS in the screening of interstitial lung diseases in connective tissue diseases. Given these data, LUS will likely play an important role in the management of COVID-19 patients from identification of specific abnormalities corresponding to definite pneumonia phases and CT scans findings. In addition, LUS could allow reduction in the exposure of health-care workers to potential infection. Herein, we provide a summary on emerging role of lung ultrasound in COVID-19 pneumonia.

Cite this article as: Lepri G, Orlandi M, Lazzeri C, Bruni C, Hughes M, Bonizzoli M, et al. The emerging role of lung ultrasound in COVID-19 pneumonia. Eur J Rheumatol 2020; 7(Suppl 2): S129-33.

EISSN 2148-4279